Vena Cava Filter

FDA-Cleared Indications

• Prevention of pulmonary embolism by filtering thrombi from the venous circulation.
• Use in patients at risk for pulmonary embolism when anticoagulant therapy is contraindicated.

Clinical Applications

• Placement in the inferior vena cava for protection against pulmonary embolism.
• Use in patients with venous thromboembolism who cannot receive anticoagulant medication.
• Use when protection from embolization is clinically needed during management of thromboembolic disease.

Reported off-label uses

• Temporary protection from pulmonary embolism in selected trauma or critically ill patients when anticoagulation is not possible.
• Use in selected patients with recurrent pulmonary embolism despite therapeutic anticoagulation.

Off-label use: these uses are reported in practice or the literature but are not part of the FDA-cleared indications. Physicians may use a cleared device off-label based on their medical judgment; the manufacturer may not promote off-label uses.

Practical Considerations

• The filter is intended for placement in the inferior vena cava and requires appropriate vessel imaging and sizing before deployment.
• Access is commonly obtained through a femoral or internal jugular vein, with fluoroscopic or other imaging guidance.
• The original Vena-Tech filter is generally considered a permanent filter; retrieval should not be assumed unless the specific device labeling and clinical assessment support it.
• Long-term risks can include filter thrombosis, migration, penetration of the vena cava wall, fracture, and recurrent deep vein thrombosis.
• MRI conditions should be confirmed from the device-specific labeling and the current institutional MRI safety policy before scanning.